Taipei, Feb. 26 (CNA) National Taiwan University Hospital (NTUH) has consulted with the United States and is to start clinical trials in Taiwan of the antiviral drug remdesivir for the treatment of COVID-19 coronavirus, the Central Epidemic Command Center (CECC) said Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares close up 0.2%
12/11/2023 01:53 PM - Politics
Parties draw lots for placement on Taiwan's presidential ballot
12/11/2023 12:32 PM - Society
Mercury forecast to soar past 30 degrees Monday in western Taiwan
12/11/2023 11:49 AM - Business
U.S. dollar up in Taipei trading
12/11/2023 10:24 AM - Society
Taiwan headline news
12/11/2023 10:22 AM